Concepedia

Ekaterina Shevchenko

ES

Statistics

Publications

5

Citations

89

H-Index

5

Active since

2020

Affiliations

University of Tübingen(Current)

University of Eastern Finland

University Children's Hospital Tübingen

Ekaterina Shevchenko is an author at University of Tübingen specializing in pharmacology, ligand binding, and drug discovery.

ORCID

Publications per year

2020–2024

5

Publications

5

Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors

Florian Wittlinger, Blessing C. Ogboo, Ekaterina Shevchenko et al. · Communications Chemistry · 2024 · 24 citations · Full text

, , +16

The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma

Stephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko et al. · Nature Communications · 2024 · 20 citations · Full text

, , +17

Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation

Alp Bayrak, Florian Mohr, Kyra Kolb et al. · Journal of Medicinal Chemistry · 2022 · 19 citations · Full text

, , +17

The autoinhibited state of MKK4: Phosphorylation, putative dimerization and R134W mutant studied by molecular dynamics simulations

Ekaterina Shevchenko, Antti Poso, Tatu Pantsar · Computational and Structural Biotechnology Journal · 2020 · 14 citations · Full text

, , +17

Shifting the selectivity of pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily

Marcel Rak, Roberta Tesch, Lena M. Berger et al. · European Journal of Medicinal Chemistry · 2023 · 12 citations · Full text

, , +8

1–5 of 5